Top ▲

Antimalarial ligands

Overview

« Hide

This family contains agents that are used for the prevention and/or treatment of malaria infection. It includes approved drugs, clinical candidates and investigational compounds.

Ligands

Ligands of relevance to immunopharmacology are highlighted in blue

ACT-451840 Show summary » More detailed page

amodiaquine Show summary » More detailed page

AN3661 Show summary » More detailed page

AN13762 Show summary » More detailed page

AQ-13 Show summary » More detailed page

artefenomel Show summary » More detailed page

arteflene Show summary » More detailed page

artemether Show summary » More detailed page

artemisinin Show summary » More detailed page

artemotil Show summary » More detailed page

artenimol Show summary » More detailed page

artesunate Show summary » More detailed page

atovaquone Show summary » More detailed page

azithromycin Show summary » More detailed page

BRD3444 Show summary » More detailed page

CDRI-97/78 Show summary » More detailed page

chloroquine Show summary » More detailed page

cipargamin Show summary » More detailed page

cladosporin Show summary » More detailed page

compound 1u [PMID: 30245402] Show summary » More detailed page

compound 3a [PMID: 30344903] Show summary » More detailed page

compound 5 [PMID: 30894487] Show summary » More detailed page

compound 34c [PMID: 24641010] Show summary » More detailed page

compound 55 [PMID: 29889526] Show summary » More detailed page

cycloguanil Show summary » More detailed page

doxycycline Show summary » More detailed page

DSM265 Show summary » More detailed page

DSM421 Show summary » More detailed page

ELQ-300 Show summary » More detailed page

ferroquine Show summary » More detailed page

forodesine Show summary » More detailed page

fosmidomycin Show summary » More detailed page

ganaplacide Show summary » More detailed page

halofantrine Show summary » More detailed page

halofuginone Show summary » More detailed page

hydroxychloroquine Show summary » More detailed page

JPC-3210 Show summary » More detailed page

lumefantrine Show summary » More detailed page

M5717 Show summary » More detailed page

mefloquine Show summary » More detailed page

mepacrine Show summary » More detailed page

ML10 Show summary » More detailed page

MMV008138 Show summary » More detailed page

MMV024101 Show summary » More detailed page

MMV048 Show summary » More detailed page

MMV253 Show summary » More detailed page

naphthoquine Show summary » More detailed page

NPC1161B Show summary » More detailed page

OSM-S-38 Show summary » More detailed page

P218 Show summary » More detailed page

piperaquine Show summary » More detailed page

primaquine Show summary » More detailed page

proguanil Show summary » More detailed page

pyrimethamine Show summary » More detailed page

pyronaridine Show summary » More detailed page

quinidine Show summary » More detailed page

quinine Show summary » More detailed page

SC83288 Show summary » More detailed page

(+)-SJ733 Show summary » More detailed page

sulfadoxine Show summary » More detailed page

sulfalene Show summary » More detailed page

tafenoquine Show summary » More detailed page

TCMDC-125163 Show summary » More detailed page

tebuquine Show summary » More detailed page

UCT943 Show summary » More detailed page

Further reading

Show »

How to cite this family page

Database page citation:

Antimalarial ligands. Accessed on 19/08/2019. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=999.